Humana is ending Medicare Advantage plans affecting about 600,000 members in 2027. Learn key enrollment dates, Medigap rights ...

Humana's cutting 600,000 members next year — and expects to rescue fewer than half. Here's how to protect yourself fast.

A new research study finds an association between pharmacy care coordination services and improved health outcomes for cancer patients.

The insurer said the move is part of a broader effort to improve profitability by exiting lower-performing plans.

During Humana’s recent earnings call, the health insurance company announced it will drop some of its Medicare Advantage ...

Humana has outperformed the broader Dow Jones index over the past year. Moreover, Wall Street analysts remain moderately ...

Shares of Humana plunged after the health insurer issued a full-year earnings guidance that was about half of Wall Street's expectations. The company cited soaring medical costs that dogged insurance ...

The insurer says it paid medical expenses for Medicare Advantage members who settled Roundup claims without reimbursing the ...

Humana (NYSE: HUM) currently trades around $355 per share, nearly 30% below its peak level of $495 seen in September 2022. In comparison, UnitedHealth stock (NYSE: UNH) saw its stock rise 13% over the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Humana reported second-quarter net income of $694 million, with revenue jumping to $40.8 ...

Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% ...

By Mike Scarcella WASHINGTON, Aug 13 (Reuters) - Health insurer Humana has agreed not to refer to drugmaker Teva as an Israeli company at an upcoming U.S. drug price-fixing trial, after the drugmaker ...